Leonard D. Schaeffer Professor of Health Care Policy and Director of the Healthcare Markets and Regulation (HMR) Lab
Harvard Medical School
President and Chief Executive Officer
NewYork-Presbyterian
Bruce V. Rauner Professor of Business Administration
Harvard Business School
Senior Vice President and Chief Transformation Officer
NewYork-Presbyterian
Executive Vice President and Chief Operating Officer
NewYork-Presbyterian
Strategic Business Development and Corporate Ventures
Verily
Editor-in-Chief and Editorial Board Co-Chair, NEJM Catalyst Innovations in Care Delivery; Chief Medical Officer, Press Ganey Associates; Editorial Board, New England Journal of Medicine
Executive Editor, NEJM Catalyst Innovations in Care Delivery; Center for Healthcare Delivery Sciences, Brigham and Women's Hospital
Vice Chairman and Global Co-Head of Healthcare
Lazard
Senior Vice President and Head of Corporate Product
Optum
President and Chief Executive Officer,
Renown Health
Steven J. Corwin, MD, is President and Chief Executive Officer of NewYork-Presbyterian, one of the nation’s largest, most comprehensive health care delivery networks.
Under Dr. Corwin’s leadership, NewYork-Presbyterian has nearly doubled in size and comprises four divisions dedicated to providing world-class care to more than 2 million patients per year. Together with its academic partners — Weill Cornell Medicine and Columbia University College of Physicians and Surgeons — NewYork-Presbyterian pursues clinical excellence, engages in pioneering medical research, and provides outstanding medical education to the next generation of doctors. The organization’s six-campus academic medical center, NewYork-Presbyterian Hospital, has been the top-ranked hospital in New York on U.S. News & World Report’s annual survey of “Best Hospitals” and among the top 10 hospitals nationwide for more than a decade.
A cardiologist and internist, Dr. Corwin obtained his undergraduate and medical degrees from Northwestern University, graduating summa cum laude and with Alpha Omega Alpha honors. He completed both his internal medicine residency and cardiology training at Columbia-Presbyterian Medical Center. Dr. Corwin joined the NewYork-Presbyterian team in 1979. From 1998 to 2005, Dr. Corwin was the organization’s Senior Vice President and Chief Medical Officer, where he led the development and implementation of 13 clinical service lines, a critical step for the success of the newly merged Hospital.
Prior to his appointment as CEO, Dr. Corwin served as NewYork-Presbyterian Hospital’s Executive Vice President and Chief Operating Officer, where he oversaw day-to-day operations across five campuses and was responsible for advancing a number of strategic initiatives, with We Put Patients First at the core of its mission. These included an intense focus on quality and patient safety, cultivating talented employees and caregivers, advancing clinical and technological innovation, building physician and institutional relationships, providing care to underserved communities, and maintaining the hospital’s financial and operational strength.
As President and CEO, Dr. Corwin has thoroughly embraced innovative approaches to patient-centered care. He led the way in establishing the NewYork-Presbyterian Regional Hospital Network and NewYork-Presbyterian Medical Groups, which enable patients to receive NewYork-Presbyterian’s world-renowned care directly in their own communities. He has overseen the planning and construction of several state-of-the-art facilities, such as The Spine Hospital at NewYork-Presbyterian/Allen and the David H. Koch Center, the largest freestanding building dedicated to ambulatory care in Manhattan’s Upper East Side, which opened in 2018. He has championed numerous technological initiatives, including on-demand access to electronic medical records for patients, a telehealth program that launched in 2016, and a dedicated space at Blueprint Health, one of the country’s leading incubators of health care technology. In addition, his focus on energy efficiency and green buildings has garnered a record number of EPA ENERGY STAR Partner of the Year Awards for Sustained Excellence in Energy Management, the program’s highest honor.
Dr. Corwin is Chairman of the Healthcare Association of New York State and the Chair of the Health Care Systems Council of the American Hospital Association. He was past chairman of the Greater New York Hospital Association. In addition, he is a Board Member at the New York Academy of Medicine. He is also a member of the Association of American Medical Colleges Council of Teaching Hospitals Administrative Board, a member of the Health Management Academy, and a member of the Advisory Board for the Morgan Stanley Institute for Sustainable Investing.
He has received numerous awards and honors, including the Hope and Heroes Award for promoting excellence in pediatric oncology and the VHA Award for Clinical Quality for the design and implementation of an emergency department for chest pain diagnosis and treatment protocol.
Peter M. Fleischut, MD, is Senior Vice President and Chief Transformation Officer for NewYork Presbyterian. In this role, he leads NYP’s Epic implementation, Telehealth, Artificial Intelligence, and pharmacy operations. Dr. Fleischut is also responsible for the development of the NYP OnDemand suite of digital health services and the implementation of clinical operations for the new David H. Koch Center at NewYork-Presbyterian/Weill Cornell. A graduate of Jefferson Medical College and the Wharton Program for Working Professionals at the University of Pennsylvania, Dr. Fleischut joined NewYork-Presbyterian Hospital/Weill Cornell in 2006 and has held the roles of Medical Director of the Operating Rooms, Deputy Quality Patient Safety Officer, Founding Director of the Center for Perioperative Outcomes, Vice Chairman, Chief Medical Information Officer, Chief Innovation Officer, and Chief Medical Operating Officer. In 2016, he was appointed Vice Chair of the Department of Anesthesiology at Weill Cornell Medical College, where he is an Assistant Professor of Anesthesiology. Dr. Fleischut has received numerous awards and honors, including NewYork-Presbyterian’s Physician of the Year, Modern Healthcare Up and Comers, Becker’s Hospital Review 40 under 40, and the American Telehealth Association President’s Award.
Dr. Laura L. Forese is Executive Vice President and Chief Operating Officer of NewYork-Presbyterian, an academic integrated delivery system of academic medical centers, regional, hospitals and employed physicians in metro New York.
More than 2 million people receive care each year at NewYork-Presbyterian, which is affiliated with the medical schools of Columbia and Cornell. NewYork-Presbyterian’s multi-campus academic medical center has been the top-rated hospital in New York on U.S. News and World Report’s annual survey of “Best Hospitals” for 17 consecutive years and among the top 10 hospitals nationwide for the past 14 years. Dr. Forese has been affiliated with NewYork-Presbyterian throughout her career in multiple clinical and management roles. In her current role, she has ultimate operating responsibility for the enterprise, which has revenue of more than $8B and more than 40,000 employees.
An orthopaedic surgeon, Dr. Forese graduated summa cum laude and Phi Beta Kappa from Princeton University and Alpha Omega Alpha from Columbia’s College of Physicians & Surgeons. She received her MPH in health care management from Columbia’s Mailman School.
Dr. Forese chairs the board of the NIH Clinical Center, the largest research hospital in the U.S. She is a Trustee of Princeton University, a board member of the Mother Cabrini Health Foundation, and also serves as a director of Cantel Medical. A role model for women in leadership, Dr. Forese has been named among the 50 most powerful women in New York by Crain’s Business, Mother of the Year by the American Cancer Society, and the Top 25 COOs by Modern Healthcare.
Luba brings to Verily pharmaceutical, biotechnology, and digital health industry experience and expertise in building and advising innovative technology companies and providing strategic counsel to global corporations. Previously, Luba has served as Vice President of Global Business Development and Mergers & Acquisitions at Roche, where she also established and led the East Coast Innovation Hub for the Diagnostics Division. Luba is on the Board of MassBio and IRX Therapeutics, and serves as Advisor to Dana-Farber Cancer Institute as part of its Business Development Council. She is also a Lecturer at Boston University Law School and School of Management where she has taught courses in life sciences, business law, innovation, and entrepreneurship since 2014.
Luba’s career has spanned leadership roles in venture investing, business development, Mergers & Acquisitions, law, and operations, previously serving as Venture Partner at Colt Ventures; leading BD and Strategy for Pronutria, a Flagship Ventures company; and serving as Senior Mergers & Acquisitions Counsel at Pfizer Inc. Luba began her career practicing law at a leading national law firm, Wilmer Cutler Pickering Hale and Dorr, where she represented clients in securities, IP, regulatory, corporate, and litigation matters.
Luba is a recipient of several awards and honors for her work in the community, including the Science Club for Girls Catalyst Award for her commitment to advocating for women in science and technology. Luba served as nonprofit board member of Longwood Symphony Orchestra, Executive Coach for MassNextGen, Co-Chair of MassBio’s Entrepreneur’s University, and mentor and judge for MassCONNECT, MIT 100K Entrepreneurship Competition, and MassChallenge.
Dr. Thomas Lee is Chief Medical Officer of Press Ganey and an internist and cardiologist who practices at Brigham and Women’s Hospital in Boston. He is a Professor of Medicine, part time, at Harvard Medical School and Professor of Health Policy and Management at the Harvard School of Public Health. Prior to joining Press Ganey, he served as Network President for Partners Healthcare System and CEO for Partners Community HealthCare, Inc., the integrated delivery system founded by Brigham and Women’s Hospital and Massachusetts General Hospital.
He is a member of the Board of Directors of Geisinger Health System, Chairman of the Board of Directors for the Geisinger Health Plan, Geisinger Quality Options, Inc., and Geisinger Indemnity Insurance Company Board of Directors. He is also a member of the Board of Directors of Health Leads; the Board of Overseers of Weill Cornell Medical College; the Special Medical Advisory Group (SMAG) of the Veterans Administration; and the Panel of Health Advisors of the Congressional Budget Office. He is a member of the Editorial Board of the New England Journal of Medicine.
He is the author of more than 300 academic articles and four books, Chaos and Organization in Health Care, Eugene Braunwald and the Rise of Modern Medicine, An Epidemic of Empathy in Healthcare, and The Good Doctor.
Named in his honor, the Thomas H. Lee Award for Excellence in Primary Care is given each year to recognize a primary care physician at Brigham and Women’s Hospital who meets the needs of his or her patients exceptionally well.
Tom holds a bachelor’s degree in History and Science from Harvard College, a medical degree from Cornell University Medical College, and a master’s degree in Epidemiology from the Harvard School of Public Health. He lives in Milton, Massachusetts, with his wife, Dr. Soheyla Gharib, who is Chief of Medicine at Harvard University Health Services. The couple has three daughters.
Namita Seth Mohta, MD, is a physician executive with expertise in health care delivery transformation. As the Executive Editor for NEJM Catalyst Innovations in Care Delivery, she is part of the founding leadership team and has responsibility for content strategy and quality. She has been part of the founding Population Health and ACO leadership teams at both Partners Health Care and the New England Quality Care Alliance (Tufts Medical Center), both in Boston. Her responsibilities have included designing and implementing ACO strategies for Medicare, Medicaid, and Commercial populations, with a focus on scaling tailored clinical interventions, integrating analytics and measurement, and leading change management and team-based care with providers. Dr. Mohta also has industry experience as a management consultant with the Boston Consulting Group. She often consults with start-ups (currently with PatientPing, GNS Healthcare, and Day Health Strategies) to provide strategic and technical expertise and leadership. Dr. Mohta practices internal medicine at the Brigham and Women’s Hospital and is faculty at The Center for Healthcare Delivery Sciences and at Harvard Medical School. She completed her Internal Medicine and Primary Care residency training at the Brigham and Women’s Hospital. Dr. Mohta is a graduate of Yale College and Yale School of Medicine.
Peter R. Orszag joined Lazard as a Managing Director and Vice Chairman of Investment Banking in May 2016. He also serves as Global Co-Head of Healthcare and is based in New York.
Prior to joining Lazard, Peter was with Citigroup (2011–2016), where he was Vice Chairman of Corporate and Investment Banking and Chairman of the Financial Strategy and Solutions Group. Before that he was the Director of the Office of Management and Budget (2009–2010), serving in President Barack Obama’s cabinet, and Director of the Congressional Budget Office (CBO) (2007–2008).
Before leading the CBO, Peter was a senior fellow in economic studies at the Brookings Institution. He previously served in the Clinton Administration, on both the Council of Economic Advisers staff and the National Economic Council.
Peter is a board member of the Mount Sinai Medical Center, the Peterson Institute for International Economics, and the Russell Sage Foundation, among other boards. He is also a member of the National Academy of Medicine.
Princeton University, AB, summa cum laude in economics; London School of Economics, PhD, economics (Marshall Scholar)
Nick Seddon joined Optum in late 2016 as an Executive in Residence. In August 2017, he became Head of Corporate Product, with a responsibility for driving common frameworks for product management; improving insights into the performance of the portfolio; and identifying and supporting enterprise growth opportunities. In the past year he has built a strong team that is transforming Optum’s approach toward product, integrated solutions, and the harnessing of Agile methodology.
Before joining the company, Nick served as special advisor for health, social care, and life sciences for UK Prime Minister David Cameron. In this role, Nick was a leader in developing and implementing strategies to ensure the long-term sustainability of the UK’s National Health Service (NHS), through the development of major initiatives such as the NHS’s 2014 “Five Year Forward View” and the “Seven Day Services” agenda. Working with NHS leaders and experts, he helped set and finance all key service priorities, including for cancer, mental health, and maternity services, the fight against childhood obesity, and the Prime Minister’s program to sequence 100,000 whole genomes. During the UK’s G8 presidency, Nick worked with Prime Minister Cameron and other international stakeholders to bring the fight against dementia to the forefront of the global policy agenda. Nick also provided day-to-day counsel for the Prime Minister on key health care and social services issues.
Prior to his position at No. 10 Downing Street, Nick was Deputy Director of Reform, a leading UK think tank focusing on public services and the economy. Previously, he worked in the private sector at Circle Health, then the UK’s fastest growing health care company. He has authored many publications in national newspapers and journals, as well as a number of books and reports, and appeared frequently on television and radio. He holds an MA and MPhil from Magdalene College at the University Cambridge. In July 2016, he was awarded an MBE by the Queen.
Dr. Anthony Slonim is an innovator and proven leader in health care on both the regional and national levels. During his notable career at major health care organizations and academic institutions, Dr. Slonim has developed a national profile as an expert in patient safety, accountable care, health care quality, and innovative care delivery models focused on improving health within the community. He is an academic leader and tenured professor with more than 100 publications and 15 textbooks to his name. He currently holds appointments as Clinical Professor in the Departments of Internal Medicine and Pediatrics at the University of Nevada, Reno School of Medicine.
Since joining Renown Health in July 2014, Dr. Slonim has completely reoriented northern Nevada’s largest locally governed, not-for-profit health care network. He launched a five-year strategic plan that is focused on the community’s overall health while embracing the national Triple Aim initiatives of improving quality care and patient satisfaction — all while reducing costs. Dr. Slonim also ushered in a new era of national collaboration to establish a medical training campus at Renown, expand the region’s quaternary care services in collaboration with Stanford Medicine, and launched the nation’s first-ever community-based, population health study with Desert Research Institute and personal genetics company Helix.
While effectively leading and managing the complexity of Renown, Dr. Slonim also manages to serve as Chair-elect on the American Hospital Association’s Systems Council, Board Chair of The Certified Medical Representatives Institute, and was named the inaugural Editor-in-Chief of the Physician Leadership Journal. He is the Board Co-Chair of the Truckee Meadows Healthy Communities and a board member for the Economic Development Authority of Western Nevada.
